ALL
Pfizer’s fast-tracked leukaemia candidate could rival CAR-Ts
Richard Staines
ALL, blood cancer, cancer, Pfizer, UCB
0 Comment
Antibody-drug conjugate with FDA gets six-month review.
X
Pfizer’s fast-tracked leukaemia candidate could rival CAR-Ts
https://pharmaphorum.com/news/pfizer-files-leukaemia-antibody-us/